Do you have a patient who might benefit from FIRAZYR?

Image of FIRAZYR® (icatibant injection) product packaging

If you have an appropriate patient who would like to try FIRAZYR, you may be able to obtain a 30 mg trial dose for their use.* FIRAZYR is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age or older.

*Takeda has limited quantities of sample product available. Physicians can obtain one sample per qualified patient. Takeda reserves the right to rescind, revoke or amend this program at any time without notice.

How the FIRAZYR Sample Program works

  1. Fill out the Request a FIRAZYR Representative form below
  2. A FIRAZYR representative will contact you in 72 hours

Request a FIRAZYR representative

Complete this form and a Takeda representative will contact you in 72 hours.

* Required fields

Pharmacist
Physician
Physician's Assistant
Registered Nurse
Other
Phone
Email

By providing your information, you consent to receiving marketing and promotional communications related to hereditary angioedema (HAE) and HAE products and other information from Takeda. You hereby give consent to Takeda, its affiliates, and their agents and representatives to send communications and information to you via the contact information you have provided above. This consent will be in effect until such time as you opt out of communications from Takeda.

If, at any time, you no longer wish to receive communications from Takeda, you can opt out by calling 1-866-888-0660. Please see our privacy policy.